What's in Moberg Pharma AB's pipeline?

Moberg Pharma AB has 6 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 3 in Phase 2, 0 in Phase 1.

Which companies overlap with Moberg Pharma AB's portfolio?

Top competitors by shared drug class: Padagis LLC, Sydnexis, Inc., Timber Pharmaceuticals Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/moberg-pharma-ab.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Moberg Pharma AB — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Moberg Pharma AB pipeline: 0 marketed, 0 filed, 3 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 3 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
MOB015B	MOB015B	phase 3	Topical antifungal	Dermatology
K301	K301	phase 3	Antifungal agent	Dermatology
MOB015B vehicle	MOB015B vehicle	phase 3		Dermatology

Therapeutic area mix

Dermatology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Padagis LLC · 1 shared drug class
Sydnexis, Inc. · 1 shared drug class
Timber Pharmaceuticals Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Moberg Pharma AB:

Cite this brief

Drug Landscape (2026). Moberg Pharma AB — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/moberg-pharma-ab. Accessed 2026-06-10.